Nektar Therapeutics (0UNL.L)
USD 1.01
(-1.02%)
USD 1.01
(-1.02%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 90.12 Million | 92.05 Million | 101.9 Million | 152.91 Million | 114.61 Million | 1.19 Billion |
| Cost of Revenue | 36.64 Million | 21.63 Million | 24.89 Million | 19.47 Million | 21.37 Million | 24.41 Million |
| Gross Profit | 53.47 Million | 70.42 Million | 77.01 Million | 133.43 Million | 93.24 Million | 1.16 Billion |
| Operating Expenses | 190.9 Million | 310.65 Million | 523.11 Million | 513.36 Million | 533.27 Million | 480.97 Million |
| Selling, General and Administrative Expenses | 79.61 Million | 92.33 Million | 122.84 Million | 104.68 Million | 98.71 Million | 81.44 Million |
| Research and Development Expenses | 111.28 Million | 218.32 Million | 400.26 Million | 408.67 Million | 434.56 Million | 399.53 Million |
| Other Expenses | - | -116 Thousand | -24.41 Million | - | - | - |
| Cost and Expenses | 227.54 Million | 332.29 Million | 548.01 Million | 532.83 Million | 554.65 Million | 505.39 Million |
| Operating Income | -137.42 Million | -240.23 Million | -446.1 Million | -379.92 Million | -440.03 Million | 687.93 Million |
| Interest Expense | 25.33 Million | 28.91 Million | 47.31 Million | 37.11 Million | 46.35 Million | 42.77 Million |
| Income Tax Expense | -200 Thousand | 3.21 Million | 557 Thousand | 493 Thousand | 613 Thousand | 1.41 Million |
| Earnings before Tax | -276.25 Million | -364.98 Million | -523.28 Million | -443.94 Million | -440.05 Million | 682.72 Million |
| Net Income | -276.05 Million | -368.19 Million | -523.83 Million | -444.44 Million | -440.66 Million | 681.31 Million |
| Earnings Per Share Basic | -1.45 | -1.97 | -2.86 | -2.49 | -2.52 | 3.78 |
| Earnings Per Share Diluted | -1.45 | -1.97 | -2.86 | -2.49 | -2.52 | 3.78 |
| Weighted Average Shares Outstanding | 190 Million | 187.13 Million | 183.29 Million | 178.58 Million | 174.99 Million | 180.11 Million |
| Weighted Average Shares Outstanding (Diluted) | 190 Million | 187.13 Million | 183.29 Million | 178.58 Million | 174.99 Million | 180.11 Million |
| Gross Margin | 0.59 | 0.76 | 0.76 | 0.87 | 0.81 | 0.98 |
| EBIT Margin | -2.70 | -2.40 | -4.45 | -2.27 | -3.32 | 0.62 |
| Profit Margin | -3.06 | -4.00 | -5.14 | -2.91 | -3.84 | 0.57 |
| EBITDA | -243.1 Million | -323.87 Million | -462.96 Million | -394.32 Million | -382.7 Million | 734.3 Million |
| Earnings Before Tax Margin | -1.52 | -2.61 | -4.38 | -2.48 | -3.84 | 0.58 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 23.48 Million | 21.63 Million | 90.12 Million | 23.88 Million | 24.14 Million | 20.49 Million |
| Cost of Revenue | 9.74 Million | 8.53 Million | 36.64 Million | 7.28 Million | 12.43 Million | 6.99 Million |
| Gross Profit | 13.74 Million | 13.1 Million | 53.47 Million | 16.6 Million | 11.71 Million | 13.5 Million |
| Operating Expenses | 50.23 Million | 47.55 Million | 190.9 Million | 47.26 Million | 45.21 Million | 47.55 Million |
| Selling, General and Administrative Expenses | 20.51 Million | 20.14 Million | - | 17.32 Million | 21.14 Million | 17.86 Million |
| Research and Development Expenses | 29.72 Million | 27.4 Million | - | 29.94 Million | 24.07 Million | 29.68 Million |
| Other Expenses | -36 Thousand | -99 Thousand | -6.24 Million | 109.25 Million | - | 736 Thousand |
| Cost and Expenses | 59.97 Million | 56.09 Million | 227.54 Million | 54.54 Million | 57.64 Million | 54.54 Million |
| Operating Income | -36.48 Million | -34.45 Million | -137.42 Million | -30.66 Million | -44.86 Million | -50.59 Million |
| Interest Expense | 6.4 Million | 5.53 Million | 25.33 Million | 6.86 Million | 5.91 Million | 6.15 Million |
| Income Tax Expense | 46 Thousand | -35 Thousand | -200 Thousand | -29 Thousand | -61 Thousand | -47 Thousand |
| Earnings before Tax | -52.31 Million | -36.83 Million | -276.25 Million | -42.1 Million | -45.89 Million | -51.16 Million |
| Net Income | -52.36 Million | -36.8 Million | -276.05 Million | -42.07 Million | -45.83 Million | -51.12 Million |
| Earnings Per Share Basic | -0.25 | -0.19 | - | -0.22 | -0.24 | -0.27 |
| Earnings Per Share Diluted | -0.25 | -0.19 | - | -0.22 | -0.24 | -0.27 |
| Weighted Average Shares Outstanding | 208.82 Million | 194.74 Million | 190 Million | 191.04 Million | 190.4 Million | 189.65 Million |
| Weighted Average Shares Outstanding (Diluted) | 208.82 Million | 194.74 Million | 190 Million | 191.04 Million | 190.4 Million | 189.65 Million |
| Gross Margin | 0.59 | 0.61 | 0.59 | 0.70 | 0.49 | 0.66 |
| EBIT Margin | -1.49 | -1.52 | - | -1.21 | -1.19 | -1.39 |
| Profit Margin | -2.23 | -1.70 | -3.06 | -1.76 | -1.90 | -2.49 |
| EBITDA | -35.02 Million | -32.84 Million | - | -29 Million | -28.62 Million | -28.46 Million |
| Earnings Before Tax Margin | -1.55 | -1.59 | -1.52 | -1.28 | -1.86 | -2.47 |
HSHZY
TSFA
SMR
SMDR
601005
MRCBF